PAG
TEVA icon

Private Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History

Private Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$623K Sell
18,399
-3,489
-16% -$116K ﹤0.01% 1638
2026
Q1 		$659K Buy
21,888
+903
+4% +$29.1K ﹤0.01% 1692
2025
Q4 		$655K Buy
20,985
+8,145
+63% +$201K ﹤0.01% 1675
2025
Q3 		$259K Buy
12,840
+261
+2% +$4.58K ﹤0.01% 2171
2025
Q2 		$211K Sell
12,579
-248
-2% -$4K ﹤0.01% 2201
2025
Q1 		$197K Sell
12,827
-12,788
-50% -$228K ﹤0.01% 2105
2024
Q4 		$565K Sell
25,615
-489
-2% -$8.9K ﹤0.01% 1508
2024
Q3 		$470K Buy
26,104
+2,990
+13% +$52.3K ﹤0.01% 1647
2024
Q2 		$376K Buy
23,114
+1,093
+5% +$16.8K ﹤0.01% 1728
2024
Q1 		$310K Buy
22,021
+2,597
+13% +$32.7K ﹤0.01% 1810
2023
Q4 		$204K Buy
19,424
+4,654
+32% +$43.5K ﹤0.01% 2036
2023
Q3 		$147K Buy
14,770
+1,790
+14% +$16.7K ﹤0.01% 1925
2023
Q2 		$97.7K Sell
12,980
-200
-2% -$1.62K ﹤0.01% 1931
2023
Q1 		$117K Hold
13,180
– – ﹤0.01% 1853
2022
Q4 		$120 Sell
13,180
-1,227
-9% -$10.7K ﹤0.01% 1569
2022
Q3 		$116K Sell
14,407
-10,261
-42% -$90.7K ﹤0.01% 1764
2022
Q2 		$185K Buy
24,668
+10,851
+79% +$94.5K ﹤0.01% 1860
2022
Q1 		$130K Sell
13,817
-1,330
-9% -$11.1K ﹤0.01% 1966
2021
Q4 		$121K Sell
15,147
-1,195
-7% -$10.8K ﹤0.01% 1997
2021
Q3 		$159K Sell
16,342
-21
-0.1% -$197 ﹤0.01% 1906
2021
Q2 		$162K Buy
16,363
+585
+4% +$6.19K ﹤0.01% 1854
2021
Q1 		$182K Sell
15,778
-2,907
-16% -$33.3K ﹤0.01% 1753
2020
Q4 		$180K Sell
18,685
-324
-2% -$3.1K ﹤0.01% 1640
2020
Q3 		$171K Sell
19,009
-2,958
-13% -$31.3K ﹤0.01% 1432
2020
Q2 		$271K Buy
21,967
+2,278
+12% +$25.8K ﹤0.01% 1244
2020
Q1 		$177K Buy
19,689
+648
+3% +$6.64K ﹤0.01% 1252
2019
Q4 		$187K Sell
19,041
-14,124
-43% -$126K ﹤0.01% 1502
2019
Q3 		$156K Buy
33,165
+8,852
+36% +$67.8K ﹤0.01% 1544
2019
Q2 		$223K Sell
24,313
-9,941
-29% -$120K ﹤0.01% 1445
2019
Q1 		$536K Sell
34,254
-4,668
-12% -$82.3K 0.01% 945
2018
Q4 		$600K Buy
38,922
+5,466
+16% +$112K 0.01% 777
2018
Q3 		$721K Buy
33,456
+25,099
+300% +$583K 0.01% 832
2018
Q2 		$204K Sell
8,357
-13,156
-61% -$268K ﹤0.01% 1184
2018
Q1 		$368K Buy
+21,513
New +$420K 0.01% 793
2017
Q4 		– Sell
-21,933
Closed -$347K – 1398
2017
Q3 		$347K Buy
21,933
+10,491
+92% +$236K 0.01% 1066
2017
Q2 		$357K Sell
11,442
-6,051
-35% -$187K 0.01% 989
2017
Q1 		$559K Buy
17,493
+633
+4% +$21.6K 0.02% 772
2016
Q4 		$578K Buy
16,860
+5,503
+48% +$220K 0.02% 686
2016
Q3 		$514K Buy
11,357
+336
+3% +$17.5K 0.02% 640
2016
Q2 		$554K Buy
11,021
+2,052
+23% +$109K 0.02% 595
2016
Q1 		$474K Sell
8,969
-771
-8% -$45.2K 0.02% 596
2015
Q4 		$639K Buy
9,740
+543
+6% +$33.6K 0.03% 524
2015
Q3 		$519K Sell
9,197
-2,752
-23% -$178K 0.03% 561
2015
Q2 		$707K Buy
11,949
+501
+4% +$30.9K 0.03% 481
2015
Q1 		$713K Sell
11,448
-656
-5% -$38.1K 0.04% 453
2014
Q4 		$689K Buy
12,104
+1,925
+19% +$107K 0.04% 446
2014
Q3 		$547K Buy
10,179
+1,618
+19% +$85.7K 0.04% 485
2014
Q2 		$449K Buy
8,561
+1,683
+24% +$86K 0.04% 529
2014
Q1 		$363K Buy
+6,878
New +$318K 0.04% 512

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Private Advisor Group's TEVA Position: Q2 2026 in Review

Private Advisor Group reduced its Teva Pharmaceuticals (TEVA) stake by 16% in Q2 2026, selling an estimated $116K and leaving 18,399 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Private Advisor Group first reported a position in TEVA in Q1 2014 and has held it in 49 quarters since. The position peaked at $721K in Q3 2018. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Private Advisor Group held 18,399 shares of Teva Pharmaceuticals worth $623K as of Q2 2026.
  • Private Advisor Group sold 3,489 Teva Pharmaceuticals shares in Q2 2026, an estimated $116K.
  • Teva Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1638 holding.
  • Private Advisor Group first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
  • Private Advisor Group's Teva Pharmaceuticals position peaked at $721K in Q3 2018.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.